Design Therapeutics, Inc. (DSGN) shareholders
Close on Nov 17, 2026Market cap $615.80MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Simeon George Joint filing with SR One Capital Fund I Aggregator, LP (10.60%), SR One Capital Partners I, LP (10.60%) and 1 more | 6,607,892 | 10.70% | 13D (active) amendment | Mar 9, 2026 |
| Alex Silverstein Joint filing with Sirenia Capital Management LP (9.50%) | 5,963,936 | 9.50% | 13G (passive) | Jun 30, 2026 |
| Light Irrevocable Trust #1 dated April 22, 2019 | 3,834,355 | 6.90% | 13G (passive) amendment | Dec 31, 2024 |
| Star Irrevocable Trust #1 dated April 22, 2019 | 3,834,355 | 6.90% | 13G (passive) amendment | Dec 31, 2024 |
| Point72 Capital Advisors, Inc. Joint filing with Point72 Asset Management, L.P. (5.10%), Steven A. Cohen (5.10%) | 3,197,764 | 5.10% | 13G (passive) | Jun 8, 2026 |
| Point72 Asset Management, L.P. Joint filing with Point72 Capital Advisors, Inc. (5.20%), Steven A. Cohen (5.20%) | 2,942,719 | 5.20% | 13G (passive) | Aug 27, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of DSGN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Sr One Capital Management, LP | 6,526,476 | 10.43% | $94.44M | – | 9.09% |
| Logos Global Management LP | 3,000,000 | 4.79% | $43.41M | +1,050,000 | 1.87% |
| Baker Bros. Advisors LP | 2,678,430 | 4.28% | $38.76M | +92,452 | 0.19% |
| Driehaus Capital Management LLC | 2,661,115 | 4.25% | $38.51M | +916,128 | 0.22% |
| BlackRock, Inc. | 2,660,024 | 4.25% | $38.49M | +526,260 | 0.00% |
| Point72 Asset Management, L.P. | 2,366,453 | 3.78% | $34.24M | −356,301 | 0.04% |
| Trails Edge Capital Partners, LP | 2,001,282 | 3.20% | $28.96M | +1,149,269 | 4.60% |
| Frazier Life Sciences Management, L.P. | 1,809,854 | 2.89% | $26.19M | New | 0.57% |
| Vivo Capital, LLC | 1,612,903 | 2.58% | $23.34M | – | 2.13% |
| Vanguard Capital Management LLC | 1,571,022 | 2.51% | $22.73M | +221,172 | 0.00% |
| Caption Management, LLC | 1,118,098 | 1.79% | $16.18M | +1,031,390 | 0.08% |
| Almitas Capital LLC | 1,026,893 | 1.64% | $14.86M | −503,442 | 3.56% |
| Geode Capital Management, LLC | 958,417 | 1.53% | $13.87M | +265,899 | 0.00% |
| Sofinnova Investments, Inc. | 865,135 | 1.38% | $12.52M | New | 0.65% |
| FMR LLC | 776,462 | 1.24% | $11.24M | −21,949 | 0.00% |
| Morgan Stanley | 765,425 | 1.22% | $11.08M | +108,860 | 0.00% |
| State Street Corp | 736,221 | 1.18% | $10.65M | +76,646 | 0.00% |
| Woodline Partners LP | 700,354 | 1.12% | $10.13M | −261,147 | 0.03% |
| Dimensional Fund Advisors LP | 694,743 | 1.11% | $10.05M | +262,903 | 0.00% |
| Goldman Sachs Group Inc | 656,584 | 1.05% | $9.50M | +151,866 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 137 | 43M | 69.2% | 29 / 62 | 32 / 16 | 12M | 7M |
| Q1 2026 | 125 | 38M | 60.7% | 22 / 55 | 29 / 13 | 7M | 5M |
| Q4 2025 | 117 | 38M | 61.0% | 31 / 39 | 29 / 8 | 9M | 7M |
| Q3 2025 | 95 | 36M | 57.6% | 14 / 18 | 38 / 11 | 4M | 2M |
| Q2 2025 | 92 | 35M | 55.2% | 5 / 35 | 34 / 11 | 1M | 1M |
| Q1 2025 | 98 | 34M | 55.1% | 14 / 28 | 36 / 10 | 3M | 2M |
| Q4 2024 | 95 | 33M | 53.5% | 15 / 34 | 22 / 18 | 3M | 2M |
| Q3 2024 | 100 | 32M | 51.2% | 15 / 29 | 34 / 9 | 5M | 8M |
| Q2 2024 | 95 | 37M | 59.4% | 15 / 37 | 27 / 13 | 8M | 3M |
| Q1 2024 | 93 | 32M | 50.7% | 19 / 22 | 36 / 14 | 3M | 3M |
| Q4 2023 | 88 | 32M | 51.6% | 15 / 37 | 24 / 14 | 7M | 7M |
| Q3 2023 | 87 | 33M | 52.5% | 14 / 27 | 38 / 24 | 10M | 16M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
148 funds held DSGN in Q2 2026, 58% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of DSGN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,161,075 | 1.86% | $16.80M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 816,383 | 1.30% | $11.81M | 0.01% | Jun 30, 2026 |
| Select Biotechnology Portfolio | 534,931 | 0.85% | $5.61M | 0.11% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 373,877 | 0.60% | $5.41M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 337,104 | 0.54% | $4.11M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 288,998 | 0.46% | $4.18M | 0.03% | Jun 30, 2026 |
| iShares Biotechnology ETF | 265,739 | 0.42% | $3.85M | 0.04% | Jun 30, 2026 |
| Fidelity Enhanced Small Cap Core ETF | 204,949 | 0.33% | $2.97M | 0.05% | Jun 30, 2026 |
| Dimensional U.S. Small Cap ETF | 156,210 | 0.25% | $1.90M | 0.01% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 152,816 | 0.24% | $1.60M | 0.00% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 144,577 | 0.23% | $1.52M | 0.01% | May 31, 2026 |
| North Square Dynamic Small Cap Fund | 143,991 | 0.23% | $1.51M | 0.19% | May 31, 2026 |
| U.S. Small Cap Portfolio | 135,805 | 0.22% | $1.65M | 0.01% | Jul 31, 2026 |
| Driehaus Micro Cap Growth Fund | 135,259 | 0.22% | $1.96M | 0.33% | Jun 30, 2026 |
| Invesco Dorsey Wright SmallCap Momentum ETF | 131,349 | 0.21% | $1.38M | 0.33% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Pratik Shah | President, CEO and Chairperson, Director | 154,923 | 0.25% | Jan 5, 2026 |
| Julie Burgess | Chief Accounting Officer | – | – | Jan 5, 2026 |
| Chris Storgard | Chief Medical Officer | – | – | Jan 5, 2026 |
| Sean Jeffries | Chief Operating Officer | 810,283 | 1.29% | Jan 5, 2026 |
| Simeon George | Director, 10% owner | 6,526,476 | 10.43% | Jun 11, 2026 |
| John P. Schmid | Director | 57,639 | 0.09% | Jun 11, 2026 |
| David Shapiro | Director | – | – | Jun 11, 2026 |
| Rodney W. Lappe | Director | 133,024 | 0.21% | Jun 11, 2026 |
| Heather A. Berger | Director | 1,300 | 0.00% | Jun 11, 2026 |
| Justin D. Gover | Director | – | – | Jun 11, 2026 |
| Arsani William | Director | 3,655,000 | 5.84% | Aug 14, 2025 |
| Deepa Prasad | Director | 1,837,273 | 2.94% | Jun 12, 2025 |
| TRUST Co DUNHAM | 10% owner | – | – | Feb 7, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Arsani William Director | Aug 13, 2025 | Sale | −345,000 | $5.25 | $1.81M | 2,655,000 |
| Arsani William Director | Aug 13, 2025 | Sale | −217,627 | $5.25 | $1.14M | 1,000,000 |
| Deepa Prasad Director | Dec 18, 2024 | Sale | −3,806 | $6.27 | $23.86K | 20,000 |
| Arsani William Director | Aug 9, 2024 | Sale | −814,874 | $4.25 | $3.46M | 0 |
| Heather A. Berger Director | Mar 25, 2024 | Buy | +1,300 | $3.74 | $4.86K | 1,300 |
| John P. Schmid Director | Mar 25, 2024 | Buy | +17,809 | $3.74 | $66.61K | 26,965 |
| John P. Schmid Director | Mar 22, 2024 | Buy | +9,156 | $3.62 | $33.14K | 9,156 |
| Rodney W. Lappe Director | Sep 29, 2023 | Buy | +21,000 | $2.35 | $49.35K | 133,024 |
| Arsani William Director | Aug 29, 2023 | Buy | +1,960,000 | $2.44 | $4.78M | 3,000,000 |
| Deepa Prasad Director | Aug 29, 2023 | Buy | +12,000 | $2.31 | $27.72K | 23,806 |
| Arsani William Director | Aug 28, 2023 | Buy | +275,000 | $2.15 | $591.25K | 1,040,000 |
| Joao Siffert MD President and CEO, Director | Dec 20, 2022 | Buy | +6,300 | $8.38 | $52.79K | 132,619 |
| Sr One Capital Partners I, Lp 10% owner | Dec 20, 2022 | Buy | +40,000 | $8.14 | $325.60K | 6,526,476 |
| Simeon George Director, 10% owner | Dec 20, 2022 | Buy | +40,000 | $8.14 | $325.60K | 6,526,476 |
| Joao Siffert MD President and CEO, Director | Dec 19, 2022 | Buy | +1,150 | $8.47 | $9.74K | 126,319 |
| Sr One Capital Partners I, Lp 10% owner | Dec 19, 2022 | Buy | +360,000 | $8.63 | $3.11M | 6,486,476 |
| Simeon George Director, 10% owner | Dec 19, 2022 | Buy | +360,000 | $8.63 | $3.11M | 6,486,476 |
| Sr One Capital Partners I, Lp 10% owner | Dec 16, 2022 | Buy | +500,000 | $8.28 | $4.14M | 6,126,476 |
| Simeon George Director, 10% owner | Dec 16, 2022 | Buy | +500,000 | $8.28 | $4.14M | 6,126,476 |
| Rodney W. Lappe Director | Dec 9, 2022 | Buy | +15,000 | $7.96 | $119.40K | 112,024 |
| Stella Xu Director | Mar 22, 2022 | Sale | −1,455 | $18.63 | $27.11K | 4,129,950 |
| Arsani William Director | Mar 21, 2022 | Buy | +25,000 | $18.99 | $474.75K | 2,797,501 |
| Stella Xu Director | Mar 21, 2022 | Sale | −24,000 | $19.01 | $456.24K | 4,131,405 |
| Stella Xu Director | Mar 18, 2022 | Sale | −552,225 | $19.04 | $10.51M | 4,168,605 |
| Stella Xu Director | Mar 18, 2022 | Sale | −13,200 | $20.34 | $268.49K | 4,155,405 |
| Deepa Prasad Director | Mar 16, 2022 | Other | +11,806 | – | – | 11,806 |
| Arsani William Director | Aug 31, 2021 | Buy | +40,000 | $15.45 | $618.00K | 2,772,501 |
| Arsani William Director | Mar 30, 2021 | Buy | +700,000 | $20.00 | $14.00M | 700,000 |
| Arsani William Director | Mar 30, 2021 | Conversion | +814,874 | – | – | 814,874 |
| Arsani William Director | Mar 30, 2021 | Conversion | +1,217,627 | – | – | 1,217,627 |
| Cormorant Asset Management, LP – | Mar 30, 2021 | Conversion | +4,364,844 | – | – | 4,364,844 |
| Cormorant Asset Management, LP – | Mar 30, 2021 | Buy | +750,000 | $20.00 | $15.00M | 5,114,844 |
| Rodney W. Lappe Director | Mar 30, 2021 | Buy | +5,000 | $20.00 | $100.00K | 97,024 |
| Stella Xu Director, 10% owner | Mar 30, 2021 | Conversion | +280,991 | – | – | 4,720,830 |
| Stella Xu Director, 10% owner | Mar 30, 2021 | Buy | +10,000 | $20.00 | $200.00K | 4,730,830 |
| Stella Xu Director, 10% owner | Mar 30, 2021 | Conversion | +4,439,839 | – | – | 4,439,839 |
| Simeon George Director, 10% owner | Mar 30, 2021 | Conversion | +936,637 | – | – | 5,376,476 |
| Simeon George Director, 10% owner | Mar 30, 2021 | Buy | +250,000 | $20.00 | $5.00M | 5,626,476 |
| Simeon George Director, 10% owner | Mar 30, 2021 | Conversion | +4,439,839 | – | – | 4,439,839 |
| Pratik Shah Executive Chairperson, Director | Mar 30, 2021 | Buy | +25,000 | $20.00 | $500.00K | 25,000 |
| Pratik Shah Executive Chairperson, Director | Mar 30, 2021 | Conversion | +104,923 | – | – | 129,923 |
| Quan Venture Fund II, L.P. 10% owner | Mar 30, 2021 | Conversion | +280,991 | – | – | 4,720,830 |
| Quan Venture Fund II, L.P. 10% owner | Mar 30, 2021 | Conversion | +4,439,839 | – | – | 4,439,839 |
| Sean Jeffries Chief Operating Officer | Mar 30, 2021 | Buy | +3,050 | $20.00 | $61.00K | 3,050 |
| Arsani William Director | Mar 30, 2021 | Conversion | +814,874 | – | – | 2,032,501 |
| Arsani William Director | Mar 30, 2021 | Buy | +700,000 | $20.00 | $14.00M | 2,732,501 |
| Arsani William Director | Mar 30, 2021 | Conversion | +1,217,627 | – | – | 1,217,627 |
| Sr One Capital Management, Llc 10% owner | Mar 30, 2021 | Buy | +250,000 | $20.00 | $5.00M | 5,626,476 |
| Sr One Capital Management, Llc 10% owner | Mar 30, 2021 | Conversion | +4,439,839 | – | – | 4,439,839 |
| Sr One Capital Management, Llc 10% owner | Mar 30, 2021 | Conversion | +936,637 | – | – | 5,376,476 |
| Justin Thacker Vice President, Finance | Mar 30, 2021 | Buy | +17,500 | $20.00 | $350.00K | 17,500 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Design Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 6,929 shares on Aug 26, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Logos Global Master Fund LP Director | Nov 18, 2025 | 120,000 | $891.60K | Nov 18, 2025 | open market |
| Logos Global Master Fund LP Director | Nov 14, 2025 | 620,000 | $4.38M | Nov 14, 2025 | open market |
| Logos Global Master Fund LP Director | Nov 7, 2025 | 415,000 | $2.85M | Nov 7, 2025 | Open market |
| Logos Opportunities Fund II LP Director | Aug 13, 2025 | 217,627 | $1.08M | Aug 13, 2025 | Private Market |
| Logos Global Master Fund LP Director | Aug 13, 2025 | 345,000 | $1.72M | Aug 13, 2025 | Public markets |
| Logos SPV 1 LP Director | Aug 9, 2024 | 814,874 | $3.46M | Aug 9, 2024 | Participation in Series B |
See a number that looks wrong?